Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.
Status:
Completed
Trial end date:
2014-12-05
Target enrollment:
Participant gender:
Summary
- The primary objective of the trial is to assess the single-dose relative bioavailability
of Chemi Enoxaparin (80 mg/0.8 mL) and Clexane® (80 mg/0.8 mL) administered by
subcutaneous (s.c.) injection, under fasting conditions in healthy volunteers.
- The secondary objective of the trial is to assess safety and tolerability of Chemi
Enoxaparin (80 mg/0.8 mL) and Clexane® (80 mg/0.8 mL) administered by s.c. injection,
under fasting conditions in healthy volunteers.